- News
VWV receive 18 team rankings and 46 individual rankings in the Chambers & Partners 2026 legal directory
16 Oct 2025VWV are delighted to have been recognised in the Chambers & Partners 2026 legal directory, achieving 64 rankings across 18 teams and 46 individuals, including 12 top-tier placements.
- Articles
Budget 2025: Key Financial Impacts for GPs and GP practices
17 Dec 2025This article was written by Adrian Cousens, Azets Healthcare Partner specialising in Primary Care.
- Articles
The Association of the British Pharmaceutical Industry (ABPI) has issued a policy proposal aimed at supporting the delivery of the NHS 10-Year Plan.
13 May 2025The plan is built around three core shifts in care: from hospital to community, from analogue to digital, and from treatment to prevention. These shifts reference the government’s ambition to deliver economic growth through improved health outcomes.
- Articles
NICE introduces promising improvements to the routing criteria for highly specialised technologies designed to treat rare diseases
13 May 2025The newly approved routing criteria is hoped to clearly define the circumstances for when highly specialised technologies (HSTs) will be routed to the HST programme which is designed to evaluate technologies for ultra-rare debilitating conditions.
- Articles
Sustainability - why this is now crucial for pharma business leaders?
01 Apr 2025Whether your business is in early stage drug discovery and R&D or manufacturing, supply, and distribution, every part of the pharma ecosystem is now under increasing pressure to adopt sustainable practices.- Articles
Spending on medicines and medical devices increases but VPAG clawback reach record levels
01 Apr 2025NHS spending on medicines, appliances and medical devices in England hit £19.9bn in 2023/24, with £14.6bn in branded medicine sales. However, the VPAG clawback is meanwhile expected to be an unprecedented £3.5bn in 2025, £1bn more than previously forecast